01
Cash & equivalents increased 61.7%
Cash & equivalents changed +61.7% from the comparable as-filed period.
$15.2M→$24.7MComparable → current
· Pharmaceutical Preparations
RESEARCH SNAPSHOTMinerva Neurosciences, Inc.'s latest supported as-filed period reports revenue of $0. Every value below links to its SEC accession and metric lineage.
The most important deterministic changes, ranked by magnitude, issuer history, persistence, and accounting profile.
Cash & equivalents changed +61.7% from the comparable as-filed period.
Net income changed +636.0% from the comparable as-filed period.
Operating income changed -215.4% from the comparable as-filed period. The change ranks at the 75th percentile of 4 prior comparable changes.
Each point keeps the date investors could first observe it and its accession.
NERV · as filed with the SEC · reported-date aware
Direct SEC links, filing dates, report periods, and amendment flags.
0001193125-26-346817SEC ↗10-QAug 7, 2026Period Jun 30, 20260001193125-26-339171SEC ↗8-KAug 7, 2026Period Aug 7, 20260001193125-26-339147SEC ↗4Aug 3, 2026Period Aug 3, 20260002095703-26-000006SEC ↗4Jun 5, 2026Period Jun 3, 20260001405279-26-000002SEC ↗4Jun 5, 2026Period Jun 3, 20260001610384-26-000002SEC ↗4Jun 5, 2026Period Jun 3, 20260001642015-26-000002SEC ↗Transaction semantics distinguish purchases, sales, awards, exercises, withholding, and derivatives.
| Filed / transacted | Reporting owner | Semantics | Shares | Price | Notional | Source |
|---|---|---|---|---|---|---|
| Aug 3, 2026Filed Aug 3, 2026 | Kaul InderjitDirector | Grant Or AwardDirect | 12,147 | $0 | $0 | Form 4 ↗ |
GrossPattern stores immutable raw artifacts, accession-scoped facts, parser and metric versions, dependency edges, quality state, and channel-specific publication rights. A restricted or unknown ancestor blocks the page and API automatically.
SEC source policy ↗Research & development changed +453.7% from the comparable as-filed period. The change ranks at the 100th percentile of 4 prior comparable changes.
Stock-based compensation changed +662.1% from the comparable as-filed period. The change ranks at the 75th percentile of 4 prior comparable changes.
Method note “Materiality” here is an analytical magnitude band, not a legal conclusion. Full filing-text semantic changes remain unpublished while excerpt rights and review thresholds are unresolved.
Latest supported period in this snapshot: 2026-06-30. Duration facts use direct quarterly or annual SEC contexts; GrossPattern does not manufacture missing Q4 values.
0001642053-26-000002